inRegen is an advanced biotech company built by innovators who are developing pioneering therapies that will transform the medical landscape and change patients’ lives.


Our technology regenerates diseased kidneys using a patient's own cells and may

prevent or delay dialysis or transplant. 

We aspire to cure kidney disease, not manage kidney failure

“We wanted to make a big difference, not a small difference. This was about really treating a disease, making a really big disease change, not an incremental difference.”

Henri Termeer, Biotechnology pioneer and former CEO of Genzyme


InRegen recognized by StartUp City magazine in annual listing of 15 Most Promising companies that are at
the forefront of providing BioTech and impacting the industry